Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals, Inc
NASDAQ:AMPH
Price:
26
USD
0.5%
Market Closed
Market Cap:
$1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Amphastar Pharmaceuticals, Inc
NASDAQ:AMPH
|
US |
|
Fortescue Metals Group Ltd
F:FVJA
|
AU |
|
Oversea-Chinese Banking Corporation Ltd
SGX:O39
|
SG |
Wall St Price Targets
AMPH Price Forecast
Based on 8 analysts
Based on 8 analysts
-18% Downside
from
$26
today
Amphastar Pharmaceuticals, Inc (AMPH)’s 12-month stock price forecast through October 2027 has a consensus target of $21.42, implying 18% downside. The forecast is based on price targets from 8 Wall Street analysts.
AMPH Analyst Rating
Based on 7 analysts
Based on 7 analysts
Analysts rate AMPH Hold, with 6 of 7 recommending Hold.
Amphastar Pharmaceuticals, Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AMPH's stock price target?
Price Target
21.42
USD
21.42
USD
According to Wall Street analysts, the average 1-year price target for AMPH is 21.42 USD with a low forecast of 20.2 USD and a high forecast of 31.5 USD.
What is the Revenue forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 6 years is 3%.
What is the Gross Profit forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
16%
16%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 6 years is 4%.